GlaxoSmithKline
GSK
32,53 €
Share price
0.03%
Change (1 day)
-8.97%
Change (1 year)
Categories
Market capitalization of GlaxoSmithKline (GSK)
Market cap: €66.15 Billion
As of July 2025 GlaxoSmithKline has a market cap of €66.15 Billion. This makes GlaxoSmithKline the world's 271th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of GlaxoSmithKline from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €66.15 B | -1% |
| 2024 | €66.81 B | -3.13% |
| 2023 | €68.97 B | 2.86% |
| 2022 | €67.06 B | -30.39% |
| 2021 | €96.34 B | 29.13% |
| 2020 | €74.60 B | -28.19% |
| 2019 | €103.89 B | 26.53% |
| 2018 | €82.11 B | 11.81% |
| 2017 | €73.44 B | -18.01% |
| 2016 | €89.57 B | -1.12% |
| 2015 | €90.59 B | 5.77% |
| 2014 | €85.64 B | -8.31% |
| 2013 | €93.41 B | 16.83% |
| 2012 | €79.95 B | -9.86% |
| 2011 | €88.70 B | 15.79% |
| 2010 | €76.60 B | 0.09% |
| 2009 | €76.53 B | 10.7% |
| 2008 | €69.14 B | -27.26% |
| 2007 | €95.05 B | -17.4% |
| 2006 | €115.07 B | -7.5% |
| 2005 | €124.40 B | 19.94% |
| 2004 | €103.71 B | -0.84% |
| 2003 | €104.59 B | -3.1% |
| 2002 | €107.93 B | -38.01% |
| 2001 | €174.11 B | -6.89% |
| 2000 | €186.99 B | 85% |
| 1999 | €101.08 B | -4.8% |
| 1998 | €106.17 B | 47.23% |
| 1997 | €72.11 B | 52.03% |
| 1996 | €47.43 B |
End of Day market cap according to different sources
On Jul 7th, 2025 the market cap of GlaxoSmithKline was reported to be:
€66.65 Billion
€65.79 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 AstraZeneca AZN | €183.93 B | 178.05% | 🇬🇧 UK |
 Pfizer PFE | €122.92 B | 85.82% | 🇺🇸 USA |
 Merck MRK | €173.12 B | 161.70% | 🇺🇸 USA |
 Novartis NVS | €206.72 B | 212.50% | 🇨🇭 Switzerland |
 Sanofi SNY | €101.68 B | 53.72% | 🇫🇷 France |
 Teva Pharmaceutical Industries TEVA | €16.46 B | -75.11% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | €1.05 B | -98.41% | 🇺🇸 USA |